Expressing support for the designation of September 30, 2025, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.
H. Res. 732 is a House resolution introduced in the 119th Congress by Rep. Kelly (PA) with co-sponsors Rep. Wasserman Schultz, Rep. Fitzpatrick, and Rep. Dingell. The resolution expresses support for designating September 30, 2025, as “Rare Cancer Day.” Its purpose is to highlight the challenges faced by patients with rare cancers, raise public awareness, and support efforts to improve early diagnosis and treatment. The resolution is symbolic and does not itself create new law or spending, but it signals congressional support for awareness, collaboration with the medical and scientific communities, and potential funding for research and treatment. The measure presents several factual statements about rare cancers (including statistics on prevalence, pediatric cancers, survival, and diagnostic challenges) and calls for awareness-building, partnerships, and funding to improve detection and develop better treatments.
Key Points
- 1Designate September 30, 2025 as “Rare Cancer Day” to raise awareness and support efforts to improve early diagnosis and treatment.
- 2Recognize the challenges of detecting and diagnosing rare cancers for patients, providers, and scientists.
- 3Acknowledge that rare cancers affect a substantial portion of cancer patients and that all pediatric cancers are rare.
- 4Encourage awareness-raising about rare cancer symptoms to promote earlier detection and improve survival rates, and promote partnerships with the medical and scientific communities.
- 5Support dedication of funding to explore cures and treatments for rare cancers.